Pharmacogenetics: past, present and future
- 31 October 2011
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 16 (19-20), 852-861
- https://doi.org/10.1016/j.drudis.2011.08.006
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Genetic Warfarin Dosing: Tables Versus AlgorithmsJournal of Invasive Cardiology, 2011
- The Emerging Role of Electronic Medical Records in PharmacogenomicsClinical Pharmacology & Therapeutics, 2011
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS StudyClinical Pharmacology & Therapeutics, 2010
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCIJAMA, 2010
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysisThe Lancet, 2010
- Robust Replication of Genotype-Phenotype Associations across Multiple Diseases in an Electronic Medical RecordAmerican Journal of Human Genetics, 2010
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side EffectsJournal of Invasive Cardiology, 2009
- Global variation in copy number in the human genomeNature, 2006
- The International HapMap ProjectNature, 2003
- Initial sequencing and analysis of the human genomeNature, 2001